United States· US:87233-0100_566bfade-f4bd-4d4c-892b-444ff5345285
WASKYRA
A medicinal product containing etuvetidigene autotemcel, registered in United States by Fondazione Telethon ETS.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ETUVETIDIGENE AUTOTEMCEL
- Manufacturer
- Fondazione Telethon ETS
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1187233-0100-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etuvetidigene autotemcel in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumWaskyra 2 10*6 cells/ml - 10 10*6 cells/mlFondazione Telethon ETS
- CzechiaWASKYRAFondazione Telethon ETS, Řím
- FinlandWaskyraFondazione Telethon Ets
- NetherlandsWaskyra 2-10 x 10^6 cellen/ml dispersie voor infusieFondazione Telethon
- PolandWaskyraFondazione Telethon ETS
- SwedenWaskyra 2 - 10 miljoner celler/ml Infusionsvätska, dispersionFondazione Telethon ETS
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Waskyra
- Liechtenstein · Waskyra
- Norway · Waskyra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/74f05703-0667-4f0b-8cf0-548df5ff77f3 GET /v1/drugs/74f05703-0667-4f0b-8cf0-548df5ff77f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "1000000",
"substance": "ETUVETIDIGENE AUTOTEMCEL",
"productndc": "87233-0100",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "U/mL",
"application_number": "BLA125846",
"marketing_category": "BLA"
}See everything about etuvetidigene autotemcel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.